Heart Rate Changes in Subjects With Epilepsy During an Epilepsy Monitoring Unit Admission

Cyberonics, Inc.2 sites in 1 country98 target enrollmentAugust 2010

ConditionsEpilepsy

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Epilepsy
Sponsor: Cyberonics, Inc.
Enrollment: 98
Locations: 2
Primary Endpoint: Collection of physiologic data during an Epilepsy Monitoring Unit (EMU) stay
Status: Completed
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to collect continuous observational data during a clinical Epilepsy Monitoring Unit evaluation.

Detailed Description

Observational, unblinded, non-randomized, multisite study designed to collect data on up to 500 subjects undergoing evaluation for epilepsy in EMUs. Subjects currently enrolled or that previously participated in this study may be eligible for the E-30-S sub-study.

Registry

clinicaltrials.gov

Start Date

August 2010

End Date

July 2014

Last Updated

11 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Cyberonics, Inc.

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients enrolled in the study must meet all of the following criteria:
•Patient has a clinical diagnosis of epilepsy requiring evaluation in an epilepsy monitoring unit (EMU).
•Patient likely requires an EMU evaluation for a period of at least 24 hours.
•Patient is currently taking at least one antiepileptic medication.
•Patient must be in good general health and fully ambulatory.
•Patient or guardian must be willing and able to complete informed consent/assent and HIPAA authorization.

Exclusion Criteria

•Patients who meet any of the following criteria are not eligible to be enrolled in the study:
•Patients with severe psychiatric disease that in the investigator's judgment would prevent the patient's successful completion of the study.
•Patients with a history of status epilepticus.
•Patients prescribed drugs specifically for a cardiac or autonomic disorder that in the investigator's opinion would affect heart rate response. Drugs with secondary cardiac or autonomic actions are allowed.
•Patients with cardiovascular arrhythmias or cardiac disease that would preclude the ability to detect intrinsic changes in heart rate due to exercise, stress, or seizure. This would include but not be limited to chronic atrial fibrillation, chronotropic incompetence, and permanent cardiac pacemaker implantation.
•Patients with a history of dependence on alcohol or narcotic drugs within the past 2 years as defined by DSM IV-R.

Outcomes

Primary Outcomes

Collection of physiologic data during an Epilepsy Monitoring Unit (EMU) stay

Time Frame: up to 7 days

To collect continuous observational video, electroencephalogram (EEG), electrooculogram (EOG), and electrocardiogram (ECG) data during ictal and non-ictal events occurring over a clinical EMU evaluation.